Brian Powl - Chief Commercial Officer at Fate Therapeutics Inc

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Commercial Officer
Stock Symbol
FATE on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Brian Powl since 12/22/2023

Holdings reported by Brian Powl for Fate Therapeutics Inc

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 41.1K $180K $4.37 Jul 5, 2023 Direct

Transactions reported by Brian Powl for Fate Therapeutics Inc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.